|
1
|
Weihrauch MR, Re D, Bischoff S, Dietlein
M, Scheidhauer K, Krug B, Textoris F, Ansén S, Franklin J, Bohlen
H, et al: Whole-body positron emission tomography using
18F-fluorodeoxyglucose for initial staging of patients with
Hodgkin's disease. Ann Hematol. 81:20–25. 2002.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cheson BD: Role of functional imaging in
the management of lymphoma. J Clin Oncol. 29:1844–1854.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cheson BD, Fisher RI, Barrington SF,
Cavalli F, Schwartz LH, Zucca E and Lister TA: Alliance
Australasian Leukaemia and Lymphoma Group; Eastern Cooperative
Oncology Group et al. Recommendations for initial
evaluation, staging, and response assessment of hodgkin and
non-hodgkin lymphoma: The lugano classification. J Clin Oncol.
32:3059–3068. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gallamini A and Zwarthoed C: Interim
FDG-PET imaging in lymphoma. Semin Nucl Med. 48:17–27.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Isidori A, de Leval L, Gergis U, Musto P
and Porcu P: Management of patients with hematologic malignancies
during the COVID-19 pandemic: Practical considerations and lessons
to be learned. Front Oncol. 10(1439)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zou S and Zhu X: FDG PET/CT of COVID-19.
Radiology. 296(E118)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Berhheim A, Mei X, Huang M, Yang Y, Fayad
ZA, Zhang N, Diao K, Lin B, Zhu X, Li K, et al: Chest CT findings
in coronavirus disease 2019 (COVID-19): relationship to duration of
infection. Radiology. 295:685–691. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Dane B, Brusca-Augello G, Kim D and Katz
DS: Unexpected findings of coronavirus disease (COVID-19) at the
lung based on abdominopelvic CT. AJR Am J Roentgenol. 215:603–605.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shi H, Han X, Jiang N, Cao Y, Alwalid O,
Gu J, Fan Y and Zheng C: Radiological findings from 81 patients
with COVID-19 pneumonia in Wuhan, China: A descriptive study.
Lancet Infect Dis. 20:425–434. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Simpson S, Kay FU, Abbara S, Bhalla S,
Chung JH, Chung M, Henry TS, Kanne JP, Kligerman S, Ko JP and Litt
H: Radiological society of North America expert consensus document
of reporting chest CT findings related to COVID-19 endorsed by the
society of thoracic radiology, the American college of radiology,
and RSNA. Radiol Cardiothorac Imaging. 2(e200152)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Playe M, Siavellis J, Braun T and Soussan
M: FDG PET/CT in a patient with mantle cell lymphoma and COVID-19:
Typical findings. Clin Nucl Med. 45:e305–e306. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chollet XLE, Robles LG, Garrastachu P,
Villegas AC, Almada MCA, Colletti PM, Rubello D, Lasanta RR and
Bolton RCD: 18F-FDG PET/CT in hodgkin lymphoma with
unsuspected COVID-19. Clin Nucl Med. 45:652–653. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zanoni L, Mosconi C, Cervati V, Diegoli M,
Monteduro F, Golfieri R and Fanti S: [18F]-FDG PET/CT
for suspected lymphoma relapse in a patient with concomitant
pneumococcal pneumonia during COVID-19 outbreak: Unexpected
SARS-Cov-2 co-infection despite double RT-PCR negativity. Eur J
Nucl Med Mol Imaging. 47:2038–2039. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Iyamu I, Wachsmann J, Truelson J, Mathews
D and Peng F: Detection of widespread metastasis in a case of
aggressive carcinoma showing thymuslike differentiation (CASTLE
Disease) Using 18F-FDG PET/CT. Clin Nucl Med. 40:689–691.
2015.PubMed/NCBI View Article : Google Scholar
|
